top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
The Department of Justice has no updates on the cannabis rescheduling process, while Representatives filed a bill directing the Department of Veterans Affairs to research psychedelics for veteran treatment. The Delaware Senate overrode a veto to prevent restrictive marijuana business zoning rules, and the Virginia House approved a bill for resentencing relief for certain marijuana offenses. In Florida, a bill to slash medical cannabis fees for veterans passed a committee. Separately, gun rights groups urged the Supreme Court to strike down the federal ban on marijuana consumers owning firearms.

DOJ has no cannabis rescheduling update as rumors swirl (Newsletter: January 30, 2026)

Jan 30, 2026

Tom Angell

Marijuana Moment



*Congressional psychedelics bill; VA marijuana resentencing; DE Senate
overrides cannabis veto; FL vets medical marijuana discount; Craft cannabis
oped*

Subscribe to receive Marijuana Moment’s newsletter in your inbox every
weekday morning. It’s the best way to make sure you know which cannabis
stories are shaping the day.
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

*Your support makes Marijuana Moment possible…*

*BREAKING*: Journalism is often consumed for free, but costs money to
produce! While this newsletter is proudly sent without cost to you, our
ability to send it each day depends on the financial support of readers who
can afford to give it. So if you’ve got a few dollars to spare each month
and believe in the work we do, please consider joining us on Patreon today.
https://www.patreon.com/marijuanamoment

*/ TOP THINGS TO KNOW*

The Department of Justice has no “comment or updates” on the cannabis
rescheduling process, a spokesperson told Marijuana Moment—more than a
month after President Donald Trump signed an executive order directing
Attorney General Pam Bondi to complete the process “in the most expeditious
manner.”

Reps. Jack Bergman (R-MI) and Lou Correa (D-CA) filed a bill directing the
Department of Veterans Affairs to carry out clinical trials on the
therapeutic efficacy of “innovative treatments and emerging
therapies”—including psychedelics such as ibogaine, 5-MeO-DMT, ketamine and
psilocybin.

The Delaware Senate voted to override Gov. Matt Meyer’s (D) veto of a
marijuana bill to block restrictive business zoning rules in counties.

The Virginia House Court of Justice Committee approved a bill to provide
resentencing relief for people incarcerated or on community supervision for
certain marijuana offenses as lawmakers separately prepare to legalize
recreational cannabis sales.

The Florida House Health Professions & Programs Subcommittee unanimously
approved a bill to slash medical cannabis patient registration fees for
military veterans—with the sponsor saying it will help them access “a much
better way of dealing with their medical issues” than opioids.

A coalition of gun rights groups led by the Second Amendment Foundation
filed a brief urging the U.S. Supreme Court to strike down the federal law
barring marijuana consumers from purchasing and possessing firearms as
unconstitutional.

Former New York cannabis regulator Damian Fagon argues in a new Marijuana
Moment op-ed that “‘craft cannabis’ functions far more as a marketing label
than as a stable economic segment” and that “the erosion of small cannabis
producers reflects policy design choices” that favor big companies.

The South Carolina House Judiciary Committee approved two hemp bills—one to
broadly ban THC products and another that provides an exception for
intoxicating cannabis beverages.

*/ FEDERAL*

A spokesperson for Health and Human Services Secretary Robert F. Kennedy Jr.
reacted to advocates’ frustration about the lack of Trump administration
progress on psychedelics reform by saying he “shares the goal of ensuring
that all Americans—especially our nation’s veterans—have access to safe and
effective treatments for conditions such as PTSD, addiction, and
depression.”

Rep. Tim Burchett (R-TN) posted a video pushing back on the notion that
marijuana legalization can raise revenue to support programs.

*/ STATES*

Ohio Gov. Mike DeWine (R) said he is open to having conversations about
allowing hemp-infused drinks, but that he will “go in with a bias” and said
the products are “not necessarily comparable to alcohol.”

The Florida Senate Criminal Justice Committee approved a bill to
decriminalize drug testing products.

New Mexico senators are dedicating portions of their budget allotments to
the Medical Psilocybin Treatment Equity Fund.

Wisconsin senators discussed their support for regulating cannabinoid
products.

Oklahoma lawmakers are considering several bills to revise medical cannabis
rules this session.

Hawaii regulators are being sued over a hemp product restriction law.

Rhode Island regulators are moving to repeal outdated hemp jurisdiction
rules.

Illinois regulators are extending the deadline for craft cannabis growers
to become operational.

California regulators published an FAQ about the state’s hemp product
restriction law.

Washington State regulators sent a newsletter with updates on various
cannabis issues.

Rhode Island regulators will host a listening session about cannabis
beverages on Monday.


*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*


*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*

*/ LOCAL*

Jersey City, New Jersey’s mayor said the City Council should pass
legislation to allow cannabis lounges to open.

*/ INTERNATIONAL*

A Canadian lawmaker is sponsoring a petition to raise the legal age for
marijuana to 25, to ban production of cannabis edibles and to revoke
licenses of companies due to odor.

*/ SCIENCE & HEALTH*

A study found that CBD is a “promising CDC123-eIF2γ inhibitor for colorectal
cancer therapy.”

A study found that “cannabidiol reduces oxycodone self-administration while
preserving its analgesic efficacy in a rat model of neuropathic pain.”

*/ ADVOCACY, OPINION & ANALYSIS*

The American Civil Liberties Union published a blog post urging the U.S.
Supreme Court to overturn the federal law barring marijuana consumers from
owning guns.

*/ BUSINESS*

Glass House Brands Inc. welcomed the chief marketing officer of Heineken,
USA to its board of directors.

Trulieve Cannabis Corp. closed a second tranche of its private placement of
senior secured notes in the principal amount of US$60.0 million.

*/ CULTURE*

Former basketball player Lamar Odom entered a drug rehabilitation program
to help quit using marijuana following a DUI arrest.

*Make sure to subscribe to get Marijuana Moment’s daily dispatch in your
inbox.*
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

The post DOJ has no cannabis rescheduling update as rumors swirl
(Newsletter: January 30, 2026) appeared first on Marijuana Moment.

Recent Reviews

bottom of page